Joseph Kim, MD

Surgical Oncologist
University of Kentucky
Lexington, Kentucky, United States

Presentation(s):

• P25. Pancreatic Cancer Derived Cancer Associated Fibroblast Inhibition of Cytotoxic T-cells is PD-L1 Dependent

  Thursday, March 5, 2026
  10:32 AM - 10:39 AM MST

• QS24. Results of a Phase II Randomized Comparison of Flat vs Weight based Mitomycin C Intraperitoneal Chemotherapy for Patients Undergoing Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

  Thursday, March 5, 2026
  3:41 PM - 3:45 PM MST

• PPS56. A Phase II Trial Evaluating Combination Cabozantinib and Pembrolizumab in Treatment Refractory Metastatic Pancreatic Adenocarcinoma

  Friday, March 6, 2026
  3:40 PM - 4:10 PM MST